Stage 1 Financial Revenue and Competitors
Estimated Revenue & Valuation
- Stage 1 Financial's estimated annual revenue is currently $17.2M per year.
- Stage 1 Financial's estimated revenue per employee is $210,000
Employee Data
- Stage 1 Financial has 82 Employees.
- Stage 1 Financial grew their employee count by -10% last year.
Stage 1 Financial's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Indirect Tax | Reveal Email/Phone |
2 | Head Onboarding | Reveal Email/Phone |
3 | Director FP&A | Reveal Email/Phone |
4 | Director Sales | Reveal Email/Phone |
5 | Marketing Manager | Reveal Email/Phone |
6 | Sales Tax Analyst | Reveal Email/Phone |
7 | Accounting Manager | Reveal Email/Phone |
8 | Accounting Manager | Reveal Email/Phone |
9 | Senior State & Local Tax Accountant | Reveal Email/Phone |
10 | Senior Account Manager | Reveal Email/Phone |
Stage 1 Financial Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 41 | 0% | N/A | N/A |
#2 | $37.7M | 163 | -10% | N/A | N/A |
#3 | $36.5M | 158 | -3% | N/A | N/A |
#4 | $6.9M | 41 | 11% | $101M | N/A |
#5 | $33.3M | 144 | 5% | N/A | N/A |
#6 | $43.2M | 187 | 8% | N/A | N/A |
#7 | $359.3M | 1222 | 37% | N/A | N/A |
#8 | $3.5M | 24 | 9% | N/A | N/A |
#9 | $6.4M | 38 | 3% | N/A | N/A |
#10 | $20M | 95 | N/A | N/A | N/A |
What Is Stage 1 Financial?
Young, fast growing companies face many challenges, one being how to manage the financial and strategic needs for a CFO and accounting department. Stage 1 Financial meets this challenge by delivering a fully outsourced finance and accounting solution which aligns with our clients organizational and strategic priorities.
keywords:N/AN/A
Total Funding
82
Number of Employees
$17.2M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Stage 1 Financial News
as well as its 2022 financial calendar ... The Company is also pursuing a Phase 1 investigator-sponsored clinical trial in first-line...
Report topline results from Part B of the Phase 1 study of ALN-HSD in patients with NASH. Financial Results for the Quarter Ended March 31, 2022.
We expect to report the initial results from a Phase 1 trial of this compound later in the year. During the quarter, we also continued...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.2M | 82 | 1% | N/A |
#2 | $17.2M | 82 | 22% | N/A |
#3 | $20.6M | 82 | 8% | N/A |
#4 | $24.1M | 83 | 6% | N/A |
#5 | $20.8M | 83 | 24% | N/A |